Back to search

ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer

Data up to Jan 2025

Published2007
Citations85
References30

Total Citations Per Year

Abstract

References (30)

Pancreatic Cancer

2000 • 7,332 citations

Cancer Statistics, 2006

2006 • 5,351 citations

Pancreatic cancer

2004 • 1,663 citations

ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions.

1995 • 507 citations

Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.

2001 • 329 citations

Metalloproteinases and their inhibitors in tumor angiogenesis

2005 • 300 citations

Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis

2005 • 207 citations

Catalytic Activity of ADAM8, ADAM15, and MDC-L (ADAM28) on Synthetic Peptide Substrates and in Ectodomain Cleavage of CD23

2003 • 176 citations

The Metalloprotease Disintegrin ADAM8

2002 • 159 citations

ADAM8 as a Novel Serological and Histochemical Marker for Lung Cancer

2004 • 145 citations

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

2002 • 144 citations

Metalloproteinase Disintegrins ADAM8 and ADAM19 Are Highly Regulated in Human Primary Brain Tumors and their Expression Levels and Activities Are Associated with Invasiveness

2006 • 138 citations

ADAM family proteins in the immune system

1999 • 137 citations

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma

2004 • 133 citations

Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration

2000 • 132 citations

Pancreatic Cancer

2006 • 127 citations

Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage

1990 • 124 citations

Ectodomain Shedding of the Neural Recognition Molecule CHL1 by the Metalloprotease-disintegrin ADAM8 Promotes Neurite Outgrowth and Suppresses Neuronal Cell Death

2004 • 122 citations

ADAMs, cell migration and cancer

2006 • 118 citations

ADAM8: A Novel Osteoclast Stimulating Factor

2001 • 106 citations

CD156 (Human ADAM8): Expression, Primary Amino Acid Sequence, and Gene Location

1997 • 104 citations

Expression and Regulation of a Disintegrin and Metalloproteinase (ADAM) 8 in Experimental Asthma

2004 • 103 citations

Oxidative Stress Induces ADAM9 Protein Expression in Human Prostate Cancer Cells

2006 • 99 citations

Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8

2006 • 82 citations

Identification of Genes Differentially Induced by Hypoxia in Pancreatic Cancer Cells

2001 • 81 citations

Aberrant Expression of a Disintegrin and Metalloproteinase 17/Tumor Necrosis Factor-α Converting Enzyme Increases the Malignant Potential in Human Pancreatic Ductal Adenocarcinoma

2006 • 68 citations

THE MEMBRANE PROTEASES ADAMS AND HEPSIN ARE DIFFERENTIALLY EXPRESSED IN RENAL CELL CARCINOMA. ARE THEY POTENTIAL TUMOR MARKERS?

2004 • 50 citations

ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis

2006 • 43 citations

Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.

2007 • 37 citations

Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative α-secretases, ADAM10 and TACE, without altering their mRNA levels

2006 • 36 citations

Cited By (0)

Loading...
ADAM8 expression is associated with increased invasiveness and reduced patient survival… (2007) – Journal of Cellular and Molecular Medicine | Metascience Observatory Explorer